Avita Medical Names Interim CEO, Reports Preliminary Q3 Revenue -- Shares Down Pre-Bell

MT Newswires Live
10/17

Avita Medical (RCEL) said late Thursday it named Chairman Cary Vance to the additional post of interim chief executive, effective immediately, replacing CEO Jim Corbett.

The company will consider internal and external candidates, including Vance, for the role of permanent CEO.

Avita Medical also said it expects preliminary Q3 revenue of around $17 million. Analysts surveyed by FactSet expect $19.2 million.

The company's shares were down nearly 20% in recent premarket activity Friday.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10